DOCS — Doximity Inc. stock price and chart

DOCS

$33.35+6.04%

as of close, Oct 20, 2026

☾ AH $33.35 +6.04%

Doximity Inc.Stock · HealthcareRussell 1000 · 0.004% of IWBRussell 3000 · 0.004% of IWVUS Stock Market · 0.004% of VTI

PeersDOCUMEDPNBIXBSYMANHEXEL

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Jun 28, 2021

VolumeEEEEEEEEEEE

20212022202420252026

20.030.040.050.060.070.080.090.0100.0050.0M$33.35

2026-10-20

Price$33.35

MA20$26.74

MA50$24.08

Vol6.4M

What would $1,000 invested in DOCS be worth today? →

DOCS returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $33.35
YTD price return: -24.68%
YTD total return: -24.68%
Next earnings: Nov 5, 2026 · After close
Market cap: 5.9B2021-06 10.8B2026-10 5.9B-44.9% over the window
Enterprise value: 5.7B
Shares outstanding: 178.2M2020-03 81.7M2026-06 178.2M+118.1% over the window
52W low: $17.15
52W high: $71.37
From 52W high: -53.27%
From 52W low: +94.46%
52W range: 30%

Volume

Rel volume: 1.38×
30D volume: 3.2M
30D $ vol: 88.6M

Fundamentals

Sales (ttm): 655.6M2020-03 116.4M2026-06 655.6M+463.3% over the window
Sales/share: $3.682020-03 $1.422026-06 $3.68+158.2% over the window
EPS (ttm): $0.852020-03 $0.132026-06 $0.85+553.8% over the window
FCF (ttm): 306.3M2020-03 25.9M2026-06 306.3M+1081.9% over the window
FCF/share: $1.722020-03 $0.322026-06 $1.72+441.8% over the window
Book value/share: $5.142020-03 $0.012026-06 $5.14+36866.3% over the window
Net margin: 25.48%2020-03 25.5%2026-06 25.5%-0.3% over the window
ROE: 18.24%2020-03 2617.7%2026-06 18.2%-99.3% over the window
ROA: 15.41%2021-03 19.9%2026-06 15.4%-22.7% over the window
Current ratio: 6.082021-03 2.052026-06 6.08+196.2% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.19%2025-06-30 → 2026-06-30589.6M → 655.6M (+11.2% total)+14.48%2023-06-30 → 2026-06-30436.9M → 655.6M (+50.1% total)+21.94%2021-06-30 → 2026-06-30243.2M → 655.6M (+169.6% total)n/a
Net income: -28.97%2025-06-30 → 2026-06-30235.1M → 167M (-29.0% total)+12.02%2023-06-30 → 2026-06-30118.8M → 167M (+40.6% total)+17.35%2021-06-30 → 2026-06-3075.1M → 167M (+122.5% total)n/a
FCF: +4.14%2025-06-30 → 2026-06-30294.1M → 306.3M (+4.1% total)+17.05%2023-06-30 → 2026-06-30191M → 306.3M (+60.4% total)+23.38%2021-06-30 → 2026-06-30107.1M → 306.3M (+185.9% total)n/a
Shares: -4.91%2025-06-30 → 2026-06-30187.5M → 178.2M (-4.9% total)-2.89%2023-06-30 → 2026-06-30194.6M → 178.2M (-8.4% total)-0.76%2021-06-30 → 2026-06-30185.2M → 178.2M (-3.8% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: -27.11%2025-06-30 → 2026-06-30$1.17 → $0.85 (-27.1% total)+15.02%2023-06-30 → 2026-06-30$0.56 → $0.85 (+52.2% total)+3.04%2021-06-30 → 2026-06-30$0.73 → $0.85 (+16.1% total)n/a
Sales/share: +16.94%2025-06-30 → 2026-06-30$3.15 → $3.68 (+16.9% total)+17.89%2023-06-30 → 2026-06-30$2.24 → $3.68 (+63.9% total)+22.88%2021-06-30 → 2026-06-30$1.31 → $3.68 (+180.1% total)n/a
FCF/share: +9.52%2025-06-30 → 2026-06-30$1.57 → $1.72 (+9.5% total)+20.53%2023-06-30 → 2026-06-30$0.98 → $1.72 (+75.1% total)+24.33%2021-06-30 → 2026-06-30$0.58 → $1.72 (+197.1% total)n/a
Book value/share: -6.07%2025-06-30 → 2026-06-30$5.47 → $5.14 (-6.1% total)+0.32%2023-06-30 → 2026-06-30$5.09 → $5.14 (+1.0% total)+5.50%2021-06-30 → 2026-06-30$3.93 → $5.14 (+30.7% total)n/a
Price: -50.98%2025-10-20 → 2026-10-20$68.00 → $33.35 (-51.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.71%2023-10-20 → 2026-10-20$22.09 → $33.35 (+51.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-14.43%2021-10-20 → 2026-10-20$72.68 → $33.35 (-54.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: -50.98%2025-10-20 → 2026-10-20$68.00 → $33.35 (-51.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+14.71%2023-10-20 → 2026-10-20$22.09 → $33.35 (+51.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-14.43%2021-10-20 → 2026-10-20$72.68 → $33.35 (-54.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 39.2×2021-06 143.582026-10 35.59-75.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 30.6×2021-06 141.652026-10 30.63-78.4% over the window
Fwd P/E: 19.9×
P/S (ttm)Market cap ÷ TTM revenue.: 9.1×2021-06 44.332026-10 9.07-79.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 6.5×2021-06 14.802026-10 6.49-56.1% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 19.4×2021-06 100.622026-10 19.41-80.7% over the window
EV/EBITDA (fy): 27.1×
EV/Sales (ttm): 8.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 5.15%2021-03 0.8%2026-06 8.3%+979.5% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($400.9M) ÷ today's market cap ($5.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 6.74%2021-03 0.0%2026-06 10.8%+57714.8% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $400.9M + TTM dividends $0) ÷ today's market cap ($5.9B). Same caveat as the cash buyback yield.: 6.74%2021-03 0.0%2026-06 10.8%+57714.8% over the window

Vs own 10Y history

P/E: 27th
P/OI: 20th
P/S: 15th
P/B: 36th
P/FCF: 13th

Bar = where today’s multiple sits in DOCS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+6.04%

+9.17%

+27.73%

+53.47%

YTD

-24.68%

-50.96%

-54.11%

Financial statements

Open full DOCS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

DOCS — Doximity Inc. price, chart and key statistics